It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The high level of meat consumption in the developed world is linked to CVD risk, presumably owing to the large content of saturated fats and cholesterol in meat
–The primary source of trans fats are refined vegetable fats (you know, the same fats our idiotic health authorities told us were “heart healthy”, then quietly backed away from when mounting evidence showed otherwise).
–Smoking, meanwhile, involves ingestion of noxious gases from nicotine-containing products, primarily cigarettes. In my four-plus decades on this crazy blue ball called Earth, I’ve yet to see someone roll a topside steak, light it up, and draw on it like a Marlboro. In other words, red meat has nothing to do with smoking, and to blame the effects of the latter on the former is sheer idiocy.
–Any claim that red meat intake causes physical inactivity is similarly absurd. In fact, given its high concentrations of B-vitamins, creatine, iron, and carnitine (critical for energy production, idiotic statements about CHD from clueless researchers notwithstanding), we would reasonably expect red meat intake to facilitate, rather than impede, strenuous exercise.
–There is no reliable evidence whatsoever to support any notion that angina, diabetes and high blood pressure are caused by red meat intake. They are, however, promoted by smoking, inactivity, and trans fat intake, all of which increased among the NHS subjects along with rising red meat intakes. These ailments are also strongly linked to such factors as high refined carbohydrate intakes, stress, ambient pollution, and high bodily iron stores.
Z.W. and B.S.L. are named as co-inventors on pending patents held by the Cleveland Clinic relating to cardiovascular diagnostics and have the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics from Liposciences. W.H.W.T. received research grant support from Abbott Laboratories and served as a consultant for Medtronic and St. Jude Medical. S.L.H. and J.D.S. are named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics patents. S.L.H. has been paid as a consultant or speaker by the following companies: Cleveland Heart Lab., Esperion, Liposciences, Merck & Co. and Pfizer. He has received research funds from Abbott, Cleveland Heart Lab., Esperion and Liposciences and has the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics.
According to an excellent report by food safety researcher Helen Bottemiller, ractopamine was originally approved by the U.S. Food and Drug Administration (FDA) back in 1999. It might surprise you, however, to learn that this approval was based solely on research data provided by Elanco, the drug's manufacturer. Unfortunately for Elanco, the regulatory processes in other countries are a little more robust than ours: Bottemiller reports that the scientist who led the European food safety panel studying the drug stated that "The main problem for us is that the safety of the product could not be supported with the data."
The results of the study found that at doses of 5mg resulted in no cardiovascular response and at 10 mg only minor effects were reported. However, at doses 15, 25, and 40 mg increased heart rate by 20, 30, and 50 beats per min above the control was reported. Cardiac output increased by approximately 35 percent, 55 percent, and 90 percent was also reported.
The reported side effects of using this drug includes tachycardia (fast heart rate, over 100 beats per minute), vasodilation (widening of blood vessel , skeletal muscle tremor, nervousness, metabolic disturbances such as hyperglycaemia (high blood sugar) and hypokalaemia (lower than normal potassium in the blood.) “These effects are pharmacologically predictable, dose-related and potency related, with cardiovascular effects being the most commonly reported side-effects. Non-pharmacological effects include airway hyper-responsiveness and increased airway inflammation” reports the National Library of Medicine.